Catalyst Pharmaceuticals (CPRX) Net Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | -26.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.01% |
| Dec 31, 2025 | -74.37% |
| Sep 30, 2025 | -44.34% |
| Jun 30, 2025 | 10.51% |
| Mar 31, 2025 | -63.48% |
| Dec 31, 2024 | 351.38% |
| Sep 30, 2024 | 215.26% |
| Jun 30, 2024 | 113.76% |
| Mar 31, 2024 | 215.07% |
| Dec 31, 2023 | -60.63% |
| Sep 30, 2023 | -228.04% |
| Jun 30, 2023 | 31.64% |
| Mar 31, 2023 | -2,267.58% |
| Dec 31, 2022 | 154.86% |
| Sep 30, 2022 | 131.07% |
| Jun 30, 2022 | 191.19% |
| Mar 31, 2022 | 338.12% |
| Dec 31, 2021 | 26.49% |
| Sep 30, 2021 | 851.36% |
| Jun 30, 2021 | -40.10% |
| Mar 31, 2021 | -123.77% |
| Dec 31, 2020 | -70.51% |
| Sep 30, 2020 | -90.48% |
| Jun 30, 2020 | 206.77% |
| Mar 31, 2020 | 385.23% |
| Dec 31, 2019 | 649.26% |
| Sep 30, 2019 | 2,860.80% |
| Jun 30, 2019 | 144.64% |
| Mar 31, 2019 | 106.66% |
| Dec 31, 2018 | -88.15% |
| Sep 30, 2018 | 158.05% |
| Jun 30, 2018 | -203.26% |
| Mar 31, 2018 | -868.71% |
| Dec 31, 2017 | 1,439.58% |
| Sep 30, 2017 | -16.29% |
| Jun 30, 2017 | 8.78% |
| Mar 31, 2017 | 34.88% |
| Dec 31, 2016 | 17.06% |
| Sep 30, 2016 | 75.87% |
| Jun 30, 2016 | 14.41% |
| Mar 31, 2016 | -118.64% |
| Dec 31, 2015 | -108.38% |
| Sep 30, 2015 | -26.38% |
| Jun 30, 2015 | -129.88% |
| Mar 31, 2015 | 2,918.26% |
| Dec 31, 2014 | 79.84% |
| Sep 30, 2014 | -129.28% |
| Jun 30, 2014 | 6,452.29% |
| Mar 31, 2014 | -49.69% |
| Dec 31, 2013 | -1.73% |
| Sep 30, 2013 | 171.00% |
| Jun 30, 2013 | 118.28% |
| Mar 31, 2013 | 41.52% |
| Dec 31, 2012 | -372.43% |
| Sep 30, 2012 | 455.40% |
| Jun 30, 2012 | 21.66% |
| Mar 31, 2012 | -193.47% |
| Dec 31, 2011 | 604.14% |
| Sep 30, 2011 | -53.50% |